Agilent is a leader in Pharmaceutical, Life Sciences, Diagnostics, and applied markets.The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent provides solutions to face the challenges during the discovery, development, and manufacture of biologics and biosimilars.Agilent has about 12500 employees globally and had revenues of $4.2 billion in fiscal year 2016.
Bio Base Europe Pilot Plant is an independent, state-of-the-art pilot facility for process development, scale-up and custom manufacturing of bio-based products and processes. A wide and flexible spectrum of modular unit operations combined with a team of highly trained and experienced engineers, process operators and technicians facilitate the translation of bio-based laboratory processes into viable industrial processes. Over the last three years Bio Base Europe Pilot Plant has successfully performed over 250 projects for more than 120 companies.
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling. By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has emerged as a global player and valuable resource to its customers in the bioprocess marketplace. Eppendorf was founded in Hamburg, Germany in 1945 and has more than 3.000 employees worldwide.
Since 1980 RIEGER represents exclusively in Austria well-known foreign manufacturers of high-tech laboratory equipment – for use in medicine, in natural science laboratories and in industrial production plants. Therefore, RIEGER focuses on offering you always the highest quality and most innovative devices.
VALIDOGEN (formerly VTU Technology) offers UNLOCK PICHIA – the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein expression / production. VALIDOGEN develops high performance expression strains and economically viable protein production processes for the manufacture of biopharmaceuticals, enzymes and various other recombinant proteins.